Latest Competition News

Invictus Energy has secured Environmental and Social Impact Assessment approval for pilot gas production at its Cabora Bassa Project, unlocking the path to commercial gas extraction and power generation in Zimbabwe.

Pantoro Limited reports exceptional high-grade gold intersections from initial drilling in the Southern Mainfield of its Norseman Gold Project, reinforcing its strategy to expand underground mining operations.

International Graphite's Springdale Project achieves over 99.95% purity in graphite purification tests coordinated by Marubeni, signaling strong potential for battery market supply.

Adore Beauty Group Limited reported a modest 2.3% revenue increase to $103 million for H1 FY25, while profits declined 36.6% due to acquisition and restructuring expenses. The company is expanding its retail footprint with new store openings planned in 2025.

Westpac’s 1Q25 update reveals a resilient $1.7 billion net profit and strong loan growth despite margin pressures and economic headwinds.

The A2 Milk Company has announced its first-ever interim dividend of NZD 0.085 per share, signaling confidence in its financial position and commitment to shareholders.

The a2 Milk Company has reported robust first-half FY25 results, boosting full-year guidance and declaring its inaugural dividend, underscoring confidence in its growth trajectory.

MinRex Resources has closed its pro-rata non-renounceable entitlement option offer, raising $97,581 with a significant shortfall still available for subscription over the next three months.

The Calmer Co. International Limited has secured a $2.64 million FJD loan from Fiji Development Bank to acquire a key Navua facility, marking a strategic step to bolster its kava processing and staff infrastructure.

Carly Holdings Limited has agreed to merge its car subscription operations with Carbar Holdings in a $3.8 million deal, aiming to create a larger, more competitive player in Australia’s growing car subscription sector.

JPMorgan Asset Management has announced updated estimated cash distributions for its Global Equity Premium Income ETFs for February 2025, providing investors with key dates and participation details.

Avecho Biotechnology has responded to an ASX price query, confirming no undisclosed information exists to explain recent trading spikes, while highlighting market speculation linked to its Phase III CBD insomnia trial.